摘要
目的研究小儿肺热咳喘口服液联合阿奇霉素治疗小儿肺炎支原体肺炎的效果。方法将江苏省淮安市洪泽区妇幼保健院儿科在2016年12月—2017年12月收治的78例小儿肺炎支原体肺炎患儿作为研究对象,将其随机分成对照组与观察组,每组各39例。两组在常规治疗的基础上,分别接受不同治疗方法,对照组仅用阿奇霉素治疗,观察组使用小儿肺热咳喘口服液联合阿奇霉素进行治疗。分析与比较两组患者的治疗效果和不良反应发生率。结果观察组的治疗总有效率为97.44%,高于对照组的治疗总有效率82.05%,组间比较,差异具有统计学意义(P <0.05)。观察组的不良反应发生率为10.27%,对照组的不良反应发生率为17.95%,观察组的不良反应发生率低于对照组,组间数据比较,差异无统计学意义(P> 0.05)。对照组患儿的喘促、发热、咳痰、咳嗽等病症消失时间均长于观察组患儿喘促、发热、咳痰、咳嗽等病症消失时间,差异具有统计学意义(P <0.05)。结论小儿肺热咳喘口服液联合阿奇霉素治疗小儿肺炎支原体肺炎的治疗效果显著,对患儿治疗效果的提高、病情的改善、不良反应的减少有重要作用。
Objective To study the effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of Mycoplasma pneumoniae pneumonia in children.Methods 78 children with Mycoplasma pneumoniae pneumonia admitted to department of pediatrics,Hongze District Maternal and Child Health Hospital at Huaian City in Jiangsu Province from December 2016 to December 2017 were selected as the study subjects.They were randomly divided into control group and observation group,39 cases in each group.On the basis of routine treatment,the two groups received different treatment methods.The control group was treated with azithromycin only.The observation group was treated with infantile febrile cough and asthma oral liquid combined with azithromycin.The therapeutic effect and incidence of adverse reactions were analyzed and compared between the two groups.Results The total effective rate of the observation group was 97.44%,which was higher than that of the control group(82.05%).There was a significant difference between the two groups(P<0.05).The incidence of adverse reactions in the observation group was 10.27%.The incidence of adverse reactions in the control group was 17.95%.The incidence of adverse reactions in the observation group was lower than that in the control group,and there was no significant difference between the two groups(P>0.05).The disappearance time of asthma,fever,expectoration and cough in the control group was higher than that in the observation group(P<0.05).Conclusion The therapeutic effect of Xiaofeirekechuan oral liquid combined with azithromycin on mycoplasma pneumoniae pneumonia in children was significant and valuable.
作者
谭祖兵
TAN Zubing(Department of Pediatrics,Hongze District Maternal and Child Health Hospital,Huaian Jiangsu 223100,China)
出处
《中国继续医学教育》
2019年第3期138-141,共4页
China Continuing Medical Education
关键词
小儿肺热咳喘口服液
阿奇霉素
小儿肺炎支原体肺炎
联合治疗
儿科
临床疗效
Xiaofeirekechuan oral liquid
azithromycin
mycoplasma pneumoniae pneumonia in children
combined therapy
clinical efficacy
adverse reactions